Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» EPO
EPO
Affymax Sell-Off: Did Investors Overreact?
Seeking Alpha
Thu, 07/8/10 - 09:27 am
Affymax
Amgen
Takeda
EPO
Epogen
Micera
Roche
investors